Verici DX - Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

Competitors: Oxford Biodynamics , Genflow Biosciences , Valirx
Registrars:

Key Personnel

CEO: Sara Barrington
Non-Executive Director: Lorenzo Gallon, James Renwick McCullough, Erik Kristian Lium
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom
Phone: +44 (0)29 2071 0570
Fax:
Website: http://www.vericidx.com/
Email:

Listings

ISIN: GB00BM8HZD43
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share